131 related articles for article (PubMed ID: 9377102)
1. Synthesis and structure-activity relationships of dual histamine H2 and gastrin receptor antagonists with noncyclic gastrin receptor antagonistic moieties.
Kawanishi Y; Ishihara S; Kiyama R; Hagishita S; Tsushima T; Ishikawa M; Ishihara Y
Bioorg Med Chem; 1997 Jul; 5(7):1425-31. PubMed ID: 9377102
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and structure-activity relationships of dual histamine H2 and gastrin receptor antagonists with decreased hydrophobicity.
Kawanishi Y; Ishihara S; Tsushima T; Hagishita S; Ishikawa M; Ishihara Y
Bioorg Med Chem; 1997 Jul; 5(7):1401-9. PubMed ID: 9377100
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and structure-activity relationships of dual histamine H2 and gastrin receptor antagonists with modified benzodiazepine skeletons.
Kawanishi Y; Ishihara S; Tsushima T; Seno K; Hagishita S; Ishikawa M; Ishihara Y
Bioorg Med Chem; 1997 Jul; 5(7):1411-23. PubMed ID: 9377101
[TBL] [Abstract][Full Text] [Related]
4. YM022, a potent and selective gastrin/CCK-B receptor antagonist, inhibits peptone meal-induced gastric acid secretion in Heidenhain pouch dogs.
Yuki H; Nishida A; Miyake A; Ito H; Akuzawa S; Takinami Y; Takemoto Y; Miyata K
Dig Dis Sci; 1997 Apr; 42(4):707-14. PubMed ID: 9125636
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and biological evaluation of a new reversely linked type of dual histamine H2 and gastrin receptor antagonist.
Kawanishi Y; Ishihara S; Takahashi K; Tsushima T; Hagishita S; Ishikawa M; Ishihara Y
Chem Pharm Bull (Tokyo); 1997 Jan; 45(1):116-24. PubMed ID: 9023973
[TBL] [Abstract][Full Text] [Related]
6. Characterization of antisecretory and antiulcer activity of CR 2945, a new potent and selective gastrin/CCK(B) receptor antagonist.
Makovec F; Revel L; Letari O; Mennuni L; Impicciatore M
Eur J Pharmacol; 1999 Mar; 369(1):81-90. PubMed ID: 10204685
[TBL] [Abstract][Full Text] [Related]
7. YF476 is a new potent and selective gastrin/cholecystokinin-B receptor antagonist in vitro and in vivo.
Takinami Y; Yuki H; Nishida A; Akuzawa S; Uchida A; Takemoto Y; Ohta M; Satoh M; Semple G; Miyata K
Aliment Pharmacol Ther; 1997 Feb; 11(1):113-20. PubMed ID: 9042983
[TBL] [Abstract][Full Text] [Related]
8. Potent and subtype-selective CCK-B/gastrin receptor antagonists: 2,4-dioxo-1,5-benzodiazepines with a plane of symmetry.
Hagishita S; Seno K; Kamata S; Haga N; Ishihara Y; Ishikawa M; Shimamura M
Bioorg Med Chem; 1997 Jul; 5(7):1433-46. PubMed ID: 9377103
[TBL] [Abstract][Full Text] [Related]
9. CCK2 receptor antagonists: pharmacological tools to study the gastrin-ECL cell-parietal cell axis.
Håkanson R; Ding XQ; Norlén P; Lindström E
Regul Pept; 1999 Mar; 80(1-2):1-12. PubMed ID: 10235629
[TBL] [Abstract][Full Text] [Related]
10. Effect of cholecystokinin-B/gastrin receptor blockade on gastric acid secretion in conscious rats.
Ding XQ; Håkanson R
Pharmacol Toxicol; 1996 Dec; 79(6):324-30. PubMed ID: 9000260
[TBL] [Abstract][Full Text] [Related]
11. FR145715, a novel histamine H2 receptor antagonist, with specific anti-Helicobacter pylori activities.
Ishikawa H; Ito H; Higaki M; Higaki M; Matsumoto Y; Kamimura T; Katsura Y; Tomishi T; Inoue Y; Takasugi H; Tomoi M; Krakowka S; Yoshida K
Eur J Pharmacol; 1999 Aug; 378(3):299-310. PubMed ID: 10493106
[TBL] [Abstract][Full Text] [Related]
12. Gastric antisecretory effect of FRG-8813, a new histamine H2 receptor antagonist, in rats and dogs.
Shibata M; Yamaura T; Inaba N; Onodera S; Chida Y; Ohnishi H
Eur J Pharmacol; 1993 Apr; 235(2-3):245-53. PubMed ID: 8099553
[TBL] [Abstract][Full Text] [Related]
13. Analysis of the variation in the action of L-365,260 at CCKB/gastrin receptors in rat, guinea-pig and mouse isolated gastric tissue assays.
Roberts SP; Harper EA; Watt GF; Gerskowitch VP; Hull RA; Shankley NP; Black JW
Br J Pharmacol; 1996 Aug; 118(7):1779-89. PubMed ID: 8842444
[TBL] [Abstract][Full Text] [Related]
14. Pharmacological analysis of the CCKB/gastrin receptors mediating pentagastrin-stimulated gastric acid secretion in the isolated stomach of the immature rat.
Hills DM; Gerskowitch VP; Roberts SP; Welsh NJ; Shankley NP; Black JW
Br J Pharmacol; 1996 Dec; 119(7):1401-10. PubMed ID: 8968549
[TBL] [Abstract][Full Text] [Related]
15. Biological activity of analogues of YM022. Novel (3-amino substituted phenyl)urea derivatives of 1,4-benzodiazepin-2-one as gastrin/cholecystokinin-B receptor antagonists.
Satoh M; Okamoto Y; Koshio H; Ohta M; Nishida A; Akuzawa S; Miyata K; Mase T; Semple G
Chem Pharm Bull (Tokyo); 1996 Jul; 44(7):1412-4. PubMed ID: 8706146
[TBL] [Abstract][Full Text] [Related]
16. (3R)-N-(1-(tert-butylcarbonylmethyl)-2,3-dihydro-2-oxo-5-(2-pyridyl)-1H-1,4-benzodiazepin-3-yl)-N'-(3-(methylamino)phenyl)urea (YF476): a potent and orally active gastrin/CCK-B antagonist.
Semple G; Ryder H; Rooker DP; Batt AR; Kendrick DA; Szelke M; Ohta M; Satoh M; Nishida A; Akuzawa S; Miyata K
J Med Chem; 1997 Jan; 40(3):331-41. PubMed ID: 9022799
[TBL] [Abstract][Full Text] [Related]
17. Antisecretory and gastroprotective activities of compounds endowed with H2 antagonistic and nitric oxide (NO) donor properties.
Coruzzi G; Adami M; Morini G; Pozzoli C; Cena C; Bertinaria M; Gasco A
J Physiol Paris; 2000; 94(1):5-10. PubMed ID: 10761682
[TBL] [Abstract][Full Text] [Related]
18. Are C-terminal octapeptide of cholecystokinin and [Leu11]gastrin-(5-17) different in stimulating acid secretion in isolated rabbit gastric glands?
Oiry C; Galleyrand JC; Lima-Leite AC; Fulcrand P; Martinez J
Eur J Pharmacol; 1995 Dec; 294(2-3):511-9. PubMed ID: 8750713
[TBL] [Abstract][Full Text] [Related]
19. Cholecystokinin type B receptor antagonist PD-136,450 is a partial secretory agonist in the stomach and a full agonist in the pancreas of the rat.
Schmassmann A; Garner A; Flogerzi B; Hasan MY; Sanner M; Varga L; Halter F
Gut; 1994 Feb; 35(2):270-4. PubMed ID: 8307482
[TBL] [Abstract][Full Text] [Related]
20. Cholecystokinin antagonists. Synthesis and biological evaluation of 4-substituted 4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepines.
Bock MG; DiPardo RM; Evans BE; Rittle KE; Veber DF; Freidinger RM; Chang RS; Lotti VJ
J Med Chem; 1988 Jan; 31(1):176-81. PubMed ID: 3336017
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
